Dosimetry during radioiodine therapy in metastatic differentiated thyroid cancer patients can change subsequent clinical strategy

被引：0
|
作者：
Chiesa, C. [1 ]
Seregni, E. [1 ]
Botta, F. [2 ]
Castellani, R. [1 ]
Bombardieri, E. [1 ]
机构：
[1] Nucl Med Ist Nazl Tumori, Milan, Italy
[2] Postgrad Med Phys Sch, Milan, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2007年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S179 / S179
页数：1
相关论文
共 50 条
  • [1] Dosimetry during radioiodine therapy in metastatic differentiated thyroid cancer.
    Castellani, M. R.
    Chiesa, C.
    Botta, F.
    Azzeroni, R.
    Negri, A.
    Mansi, D.
    Maccauro, M.
    Orunesu, E.
    Seregni, E.
    Bombardieri, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S417 - S417
  • [2] Dosimetry for radioiodine therapy of differentiated thyroid cancer in patients with renal disease on haemodialysis
    Happel, C.
    Kranert, W. T.
    Selkinski, I.
    Middendorp, M.
    Sauter, B.
    Truong, P. N.
    Wright, D.
    Diener, J.
    Gruenwald, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S356 - S356
  • [3] Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer
    Pacilio, Massimiliano
    Conte, Miriam
    Frantellizzi, Viviana
    De Feo, Maria Silvia
    Pisani, Antonio Rosario
    Marongiu, Andrea
    Nuvoli, Susanna
    Rubini, Giuseppe
    Spanu, Angela
    De Vincentis, Giuseppe
    DIAGNOSTICS, 2022, 12 (07)
  • [4] Radioiodine therapy of metastatic lesions of differentiated thyroid cancer
    Luster, M.
    Haenscheid, H.
    Freudenberg, L. S.
    Verburg, F. A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (06) : 21 - 29
  • [5] Radioiodine Therapy in Pediatric Differentiated Thyroid Cancer Dosimetry, Clinical Care, and Future Challenges
    Kumar, Praveen
    Damle, Nishikant Avinash
    Bal, Chandrasekhar
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (02) : 158 - 167
  • [6] Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy
    de Keizer, B
    Brans, B
    Hoekstra, A
    Zelissen, PMJ
    Koppeschaar, HPF
    Lips, CJM
    Rijk, PP
    Dierckx, RA
    Klerk, JMH
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (03) : 367 - 373
  • [7] Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy
    Bart de Keizer
    Boudewijn Brans
    Anne Hoekstra
    Pierre M. J. Zelissen
    Hans P. F. Koppeschaar
    Cees J. M. Lips
    Peter P. van Rijk
    Rudi A. Dierckx
    John M. H. de Klerk
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : 367 - 373
  • [8] Ten Year Experience of Radioiodine Dosimetry: is it Useful in the Management of Metastatic Differentiated Thyroid Cancer?
    Sun, F.
    Gerrard, G. E.
    Roberts, J. K.
    Telford, T.
    Namini, S.
    Waller, M.
    Flux, G.
    Gill, V. M.
    CLINICAL ONCOLOGY, 2017, 29 (05) : 310 - 315
  • [9] Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?
    Fatourechi, V
    Hay, ID
    Mullan, BP
    Wiseman, GA
    Eghbali-Fatourechi, GZ
    Thorson, LM
    Gorman, CA
    THYROID, 2000, 10 (07) : 573 - 577
  • [10] Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma
    Salvatori, Massimo
    Luster, Markus
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (04) : 821 - 828
12345